Financials
- Market Capitalization 5.63 M
- Employee 29
- Founded 2017
- CEO N/A
- Website www.bioxceltherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG00K20GVD2
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-0.28
売上高対価格比率
30.42
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 4893 | PCSA Processa Pharmaceuticals, Inc. - Common Stock | 2.07 USD | -2.82% | -0.48% | +13.11% | -6.96% | 5.78 M USD | ||
| 4899 | BGMS Bio Green Med Solution, Inc. - Common Stock | 0.86 USD | -3.37% | -1.15% | -3.37% | -85.67% | 5.70 M USD | ||
| 4909 | PMCB PharmaCyte Biotech, Inc. - Common Stock | 0.52 USD | -3.70% | -1.89% | -13.33% | -45.83% | 5.58 M USD | ||
| 4916 | CVKD Cadrenal Therapeutics, Inc. - Common Stock | 1.53 USD | -2.55% | -2.55% | -23.12% | -72.28% | 5.46 M USD |